Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five unique stocks each week that attract high reader and investor interest.
Read original at benzingaStocks · News reference
BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B Est
BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 31, 2026, 10:01 AM
- Checked
- Jul 31, 2026, 10:00 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price Target
BTIG analyst David Larsen reiterates BrightSpring Health (NASDAQ:BTSG) with a Buy and maintains $90 price target.
Read original at benzingaBrightSpring Health Services shares are trading lower despite reporting better-than-expected Q2 financial results and raising its FY26 sales guidance above estimates. The stock has gained over 600% in two years.
Read original at benzingaBrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share
Read original at benzinga